首页 > 最新文献

Journal of global antimicrobial resistance最新文献

英文 中文
Evolution of carbapenem-resistant Klebsiella pneumoniae after ceftolozane-tazobactam exposure in a patient after cord blood transplantation: A case report. 脐带血移植后患者接触头孢唑嗪-他唑巴坦后碳青霉烯耐药肺炎克雷伯菌的演变:一例报告。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-19 DOI: 10.1016/j.jgar.2026.01.008
Shuhei Kurosawa, Sohei Harada, Kohji Komori, Kaworu Takatsuna, Hitomi Ike, Yukihiro Yoshimura, Yuki Iketani, Yoko Tateishi, Hiroyuki Hayashi, Tomonori Nakazato

Objective: Infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have a poor prognosis, particularly in immunocompromised patients. While carbapenemase production is the primary resistance mechanism in CRKP, other mechanisms may contribute synergistically to carbapenem resistance. Here, we describe a case in which extended-spectrum β-lactamase (ESBL)-producing K. pneumoniae, initially susceptible to carbapenems, acquired carbapenem resistance without carbapenemase production following ceftolozane-tazobactam exposure.

Methods: Whole-genome sequencing was performed on ESBL-producing K. pneumoniae strains detected during the clinical course to investigate the relationship between the genetic characteristics and antimicrobial susceptibility, particularly to ceftolozane-tazobactam and carbapenems. Changes in the transcription levels of the beta-lactamase genes were also analyzed using reverse transcription quantitative PCR (RT-qPCR).

Results: Active surveillance stool culture before cord blood transplantation (CBT) identified colonization with an ESBL-producing K. pneumoniae strain. Febrile neutropenia occurred on day 7 after CBT and was treated empirically with ceftolozane-tazobactam. Fatal bacteremia developed on day 30 after CBT due to a carbapenemase-negative isolate resistant to both ceftolozane-tazobactam and carbapenems. Whole-genome sequencing analysis revealed that K. pneumoniae ST307 strains harboring blaCTX-M-15, blaSHV-28, and blaTEM-1B acquired a nonsense mutation in ompK36 following ceftolozane-tazobactam exposure. RT-qPCR analysis documented a significant increase in blaSHV-28 transcription after ceftolozane-tazobactam exposure.

Conclusions: This case demonstrates that K. pneumoniae without carbapenemase production can acquire carbapenem resistance through a combined resistance mechanisms following exposure to non-carbapenem antibiotics. Antimicrobial stewardship must be implemented comprehensively, not focused solely on specific antibiotics.

目的:耐碳青霉烯肺炎克雷伯菌(CRKP)引起的感染预后较差,特别是在免疫功能低下的患者中。虽然碳青霉烯酶的产生是CRKP的主要耐药机制,但其他机制可能协同促进碳青霉烯类耐药。在这里,我们描述了一个产广谱β-内酰胺酶(ESBL)的肺炎克雷伯菌,最初对碳青霉烯类药物敏感,在暴露于头孢唑嗪-他唑巴坦后,在不产碳青霉烯酶的情况下获得了碳青霉烯类药物耐药性。方法:对临床过程中检测到的产esbl肺炎克雷伯菌进行全基因组测序,研究遗传特征与抗菌药物敏感性的关系,特别是对头孢唑烷-他唑巴坦和碳青霉烯类药物的敏感性。利用反转录定量PCR (RT-qPCR)分析β -内酰胺酶基因转录水平的变化。结果:脐带血移植(CBT)前的主动监测粪便培养确定了产生esbl的肺炎克雷伯菌菌株的定植。认知行为治疗后第7天出现发热性中性粒细胞减少症,经经验应用头孢唑氮-他唑巴坦治疗。由于碳青霉烯酶阴性分离株对头孢唑烷-他唑巴坦和碳青霉烯类均耐药,在CBT后第30天发生致死性菌血症。全基因组测序分析显示,携带blaCTX-M-15、blaSHV-28和blaTEM-1B的肺炎克雷伯菌ST307菌株在暴露于头孢唑氮-他唑巴坦后获得了ompK36的无意义突变。RT-qPCR分析显示,暴露于头孢唑氮-他唑巴坦后,blaSHV-28转录显著增加。结论:本病例表明,不产生碳青霉烯酶的肺炎克雷伯菌在暴露于非碳青霉烯类抗生素后可通过联合耐药机制获得碳青霉烯类耐药性。抗菌药物管理必须全面实施,而不是仅仅集中在特定抗生素上。
{"title":"Evolution of carbapenem-resistant Klebsiella pneumoniae after ceftolozane-tazobactam exposure in a patient after cord blood transplantation: A case report.","authors":"Shuhei Kurosawa, Sohei Harada, Kohji Komori, Kaworu Takatsuna, Hitomi Ike, Yukihiro Yoshimura, Yuki Iketani, Yoko Tateishi, Hiroyuki Hayashi, Tomonori Nakazato","doi":"10.1016/j.jgar.2026.01.008","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.01.008","url":null,"abstract":"<p><strong>Objective: </strong>Infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have a poor prognosis, particularly in immunocompromised patients. While carbapenemase production is the primary resistance mechanism in CRKP, other mechanisms may contribute synergistically to carbapenem resistance. Here, we describe a case in which extended-spectrum β-lactamase (ESBL)-producing K. pneumoniae, initially susceptible to carbapenems, acquired carbapenem resistance without carbapenemase production following ceftolozane-tazobactam exposure.</p><p><strong>Methods: </strong>Whole-genome sequencing was performed on ESBL-producing K. pneumoniae strains detected during the clinical course to investigate the relationship between the genetic characteristics and antimicrobial susceptibility, particularly to ceftolozane-tazobactam and carbapenems. Changes in the transcription levels of the beta-lactamase genes were also analyzed using reverse transcription quantitative PCR (RT-qPCR).</p><p><strong>Results: </strong>Active surveillance stool culture before cord blood transplantation (CBT) identified colonization with an ESBL-producing K. pneumoniae strain. Febrile neutropenia occurred on day 7 after CBT and was treated empirically with ceftolozane-tazobactam. Fatal bacteremia developed on day 30 after CBT due to a carbapenemase-negative isolate resistant to both ceftolozane-tazobactam and carbapenems. Whole-genome sequencing analysis revealed that K. pneumoniae ST307 strains harboring bla<sub>CTX-M-15</sub>, bla<sub>SHV-28</sub>, and bla<sub>TEM-1B</sub> acquired a nonsense mutation in ompK36 following ceftolozane-tazobactam exposure. RT-qPCR analysis documented a significant increase in bla<sub>SHV-28</sub> transcription after ceftolozane-tazobactam exposure.</p><p><strong>Conclusions: </strong>This case demonstrates that K. pneumoniae without carbapenemase production can acquire carbapenem resistance through a combined resistance mechanisms following exposure to non-carbapenem antibiotics. Antimicrobial stewardship must be implemented comprehensively, not focused solely on specific antibiotics.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146018589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of tmexCD2-toprJ2-carrying carbapenem-resistant Raoultella ornithinolytica from hospital sewage in Zhejiang Province of China, 2022-2023. 2022-2023年浙江省医院污水中携带tmexd2 - toprj2的耐碳青霉烯型溶鸟拉乌尔菌的鉴定
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-12 DOI: 10.1016/j.jgar.2026.01.002
Yonglu Huang, Yi Sun, Chang Jiang, Xiangkun Zeng, Yuchen Wu, Zelin Yan, Jing Wang, Hongwei Zhou, Gongxiang Chen, Yongning Wu, Ning Dong

Objective: Hospital wastewater serves as a critical source of antimicrobial resistance genes (ARGs), particularly those associated with opportunistic pathogens like Raoultella ornithinolytica. This study aimed to characterize carbapenem-resistant R. ornithinolytica (CR-ROR) isolates carrying the tmexCD2-toprJ2 gene cluster from hospital sewage in Zhejiang province, China.

Methods: Wastewater samples collected from four hospitals in Zhejiang Province were screened for carbapenem-resistant isolates. Whole-genome sequencing using the Illumina platform, combined with bioinformatic analysis, was performed to investigate phylogenetic relationships, associated ARGs, and the structural features of plasmids in tmexCD2-toprJ2-positive CR-ROR isolates.

Results: Five genetically distantly related tmexCD2-toprJ2-positive CR-ROR isolates were identified. All exhibited multidrug-resistant (MDR) phenotypes and carried various ARGs, including carbapenemase genes such as blaKPC-2, blaNDM-1, and blaIMP-4. Genomic analysis revealed that tmexCD2-toprJ2 was plasmid-borne and frequently flanked by mobile genetic elements (MGEs), suggesting a high risk of horizontal gene transfer.

Conclusions: The presence of tmexCD2-toprJ2-carrying CR-ROR in hospital sewage underscores the role of wastewater as a potential environmental reservoir for clinically resistant genes. Ongoing surveillance of hospital effluents is crucial for tracking the dissemination of high-risk antimicrobial resistance determinants and informing timely public health interventions.

目的:医院废水是抗微生物药物耐药性基因(ARGs)的重要来源,特别是与溶鸟劳氏菌(Raoultella ornithinolytica)等机会致病菌相关的基因。本研究旨在鉴定浙江省医院污水中携带tmexCD2-toprJ2基因簇的耐碳青霉烯型溶鸟阻胞菌(CR-ROR)。方法:对浙江省4家医院的污水进行耐碳青霉烯类细菌的筛选。利用Illumina平台进行全基因组测序,结合生物信息学分析,研究tmexcd2 - toprj2阳性CR-ROR分离株的系统发育关系、相关ARGs和质粒结构特征。结果:鉴定出5株遗传亲缘关系较远的tmexd2 - toprj2阳性CR-ROR分离株。所有小鼠均表现出多药耐药表型,并携带多种ARGs,包括碳青霉烯酶基因blaKPC-2、blaNDM-1和blaIMP-4。基因组分析显示,tmexCD2-toprJ2是质粒携带的,并且经常被移动遗传元件(MGEs)包围,表明具有较高的水平基因转移风险。结论:医院污水中携带tmexd2 - toprj2的CR-ROR的存在强调了废水作为临床耐药基因的潜在环境水库的作用。持续监测医院污水对于追踪高风险抗微生物药物耐药性决定因素的传播和及时通报公共卫生干预措施至关重要。
{"title":"Characterization of tmexCD2-toprJ2-carrying carbapenem-resistant Raoultella ornithinolytica from hospital sewage in Zhejiang Province of China, 2022-2023.","authors":"Yonglu Huang, Yi Sun, Chang Jiang, Xiangkun Zeng, Yuchen Wu, Zelin Yan, Jing Wang, Hongwei Zhou, Gongxiang Chen, Yongning Wu, Ning Dong","doi":"10.1016/j.jgar.2026.01.002","DOIUrl":"10.1016/j.jgar.2026.01.002","url":null,"abstract":"<p><strong>Objective: </strong>Hospital wastewater serves as a critical source of antimicrobial resistance genes (ARGs), particularly those associated with opportunistic pathogens like Raoultella ornithinolytica. This study aimed to characterize carbapenem-resistant R. ornithinolytica (CR-ROR) isolates carrying the tmexCD2-toprJ2 gene cluster from hospital sewage in Zhejiang province, China.</p><p><strong>Methods: </strong>Wastewater samples collected from four hospitals in Zhejiang Province were screened for carbapenem-resistant isolates. Whole-genome sequencing using the Illumina platform, combined with bioinformatic analysis, was performed to investigate phylogenetic relationships, associated ARGs, and the structural features of plasmids in tmexCD2-toprJ2-positive CR-ROR isolates.</p><p><strong>Results: </strong>Five genetically distantly related tmexCD2-toprJ2-positive CR-ROR isolates were identified. All exhibited multidrug-resistant (MDR) phenotypes and carried various ARGs, including carbapenemase genes such as bla<sub>KPC-2</sub>, bla<sub>NDM-1</sub>, and bla<sub>IMP-4.</sub> Genomic analysis revealed that tmexCD2-toprJ2 was plasmid-borne and frequently flanked by mobile genetic elements (MGEs), suggesting a high risk of horizontal gene transfer.</p><p><strong>Conclusions: </strong>The presence of tmexCD2-toprJ2-carrying CR-ROR in hospital sewage underscores the role of wastewater as a potential environmental reservoir for clinically resistant genes. Ongoing surveillance of hospital effluents is crucial for tracking the dissemination of high-risk antimicrobial resistance determinants and informing timely public health interventions.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":"283-287"},"PeriodicalIF":3.2,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial resistance in the Bacteroides fragilis group: national multicenter survey and Bayesian modelling study, France, 2022-2023. 脆弱拟杆菌群的抗菌素耐药性:国家多中心调查和贝叶斯模型研究,法国,2022-2023。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-12 DOI: 10.1016/j.jgar.2026.01.003
Gauthier Delvallez, Pascal Campagne, Corentine Alauzet, Laure Diancourt, Frédéric Barbut, Hélène Marchandin, Bruno Dupuy

Objectives: Epidemiological studies on Bacteroides fragilis group (BFG) species and their antimicrobial resistance (AMR) profiles remain scarce worldwide and are lacking in France. The aim of this study was to provide comprehensive national data on the distribution of BFG species, isolation sites, AMR and its potential regional disparity.

Methods: A retrospective multicenter study was conducted from January 2022 to December 2023 using routine data from 45 French hospitals. A total of 9,458 BFG isolates identified to the species level by MALDI-ToF were included. Antimicrobial susceptibility testing (AST) was performed according to French guidelines using either disc diffusion or gradient diffusion methods. AST results were collected for ten antibiotics: amoxicillin-clavulanate (AMC), piperacillin-tazobactam (PIT), imipenem (IMI), clindamycin (CLI), metronidazole (MET), moxifloxacin, tigecycline, linezolid, rifampicin, and chloramphenicol. A Bayesian statistical model was applied to estimate regional resistance frequencies with corresponding credible intervals.

Results: Bacteroides fragilis sensu stricto (B. fragilis) was the most prevalent species (62.4%), followed by Bacteroides thetaiotaomicron (14.2%). Resistance to IMI and MET remained low, while AMC, PIT, and CLI resistance varied markedly across species: 5.2%, 3.6%, and 34.4% for B. fragilis; 18.0%, 50.1%, and 72.9% for B. thetaiotaomicron; and 32.1%, 19.5%, and 75.2% for Parabacteroides distasonis, respectively. Bayesian modelling produced robust regional estimates for B. fragilis, revealing noticeable regional disparities, particularly for AMC, PIT, and MET.

Conclusion: Bayesian modeling revealed substantial interspecies and interregional differences in BFG resistance, highlighting the importance of species-level identification and localized surveillance to inform empirical antibiotic therapy.

目的:脆弱拟杆菌群(BFG)物种及其抗菌素耐药性(AMR)谱的流行病学研究在世界范围内仍然稀缺,在法国缺乏。本研究的目的是提供有关BFG种类分布、分离点、AMR及其潜在区域差异的综合数据。方法:采用法国45家医院的常规数据,于2022年1月至2023年12月进行回顾性多中心研究。通过MALDI-ToF鉴定到种水平的BFG菌株共9458株。抗菌药敏试验(AST)按照法国指南采用碟扩散法或梯度扩散法进行。收集阿莫西林-克拉维酸酯(AMC)、哌拉西林-他唑巴坦(PIT)、亚胺培南(IMI)、克林霉素(CLI)、甲硝唑(MET)、莫西沙星、替加环素、利奈唑胺、利福平、氯霉素等10种抗生素的AST检测结果。采用贝叶斯统计模型估计具有相应可信区间的区域电阻频率。结果:严感脆弱拟杆菌(B. fragilis)最多,占62.4%,其次是太古微拟杆菌(Bacteroides thetaiotaomicron),占14.2%。对IMI和MET的抗性较低,而对AMC、PIT和CLI的抗性在不同物种间差异显著:脆弱芽孢杆菌为5.2%、3.6%和34.4%;大肠杆菌为18.0%、50.1%、72.9%;副芽孢杆菌的感染率分别为32.1%、19.5%和75.2%。贝叶斯模型对脆弱芽孢杆菌进行了可靠的区域估计,揭示了明显的区域差异,特别是对AMC、PIT和MET。结论:贝叶斯模型揭示了BFG耐药性的物种间和地区间差异,强调了物种水平鉴定和局部监测对经验性抗生素治疗的重要性。
{"title":"Antimicrobial resistance in the Bacteroides fragilis group: national multicenter survey and Bayesian modelling study, France, 2022-2023.","authors":"Gauthier Delvallez, Pascal Campagne, Corentine Alauzet, Laure Diancourt, Frédéric Barbut, Hélène Marchandin, Bruno Dupuy","doi":"10.1016/j.jgar.2026.01.003","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.01.003","url":null,"abstract":"<p><strong>Objectives: </strong>Epidemiological studies on Bacteroides fragilis group (BFG) species and their antimicrobial resistance (AMR) profiles remain scarce worldwide and are lacking in France. The aim of this study was to provide comprehensive national data on the distribution of BFG species, isolation sites, AMR and its potential regional disparity.</p><p><strong>Methods: </strong>A retrospective multicenter study was conducted from January 2022 to December 2023 using routine data from 45 French hospitals. A total of 9,458 BFG isolates identified to the species level by MALDI-ToF were included. Antimicrobial susceptibility testing (AST) was performed according to French guidelines using either disc diffusion or gradient diffusion methods. AST results were collected for ten antibiotics: amoxicillin-clavulanate (AMC), piperacillin-tazobactam (PIT), imipenem (IMI), clindamycin (CLI), metronidazole (MET), moxifloxacin, tigecycline, linezolid, rifampicin, and chloramphenicol. A Bayesian statistical model was applied to estimate regional resistance frequencies with corresponding credible intervals.</p><p><strong>Results: </strong>Bacteroides fragilis sensu stricto (B. fragilis) was the most prevalent species (62.4%), followed by Bacteroides thetaiotaomicron (14.2%). Resistance to IMI and MET remained low, while AMC, PIT, and CLI resistance varied markedly across species: 5.2%, 3.6%, and 34.4% for B. fragilis; 18.0%, 50.1%, and 72.9% for B. thetaiotaomicron; and 32.1%, 19.5%, and 75.2% for Parabacteroides distasonis, respectively. Bayesian modelling produced robust regional estimates for B. fragilis, revealing noticeable regional disparities, particularly for AMC, PIT, and MET.</p><p><strong>Conclusion: </strong>Bayesian modeling revealed substantial interspecies and interregional differences in BFG resistance, highlighting the importance of species-level identification and localized surveillance to inform empirical antibiotic therapy.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145984944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intervention studies and antimicrobial resistance in Italy: An overview of the latest evidence. 意大利的干预研究和抗菌素耐药性:最新证据概述。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-08 DOI: 10.1016/j.jgar.2025.12.017
Antonio Vitiello, Andrea Zovi, Michela Sabbatucci, Elisa Fabbro, Walter Ricciardi, Leonardo Villani, Giovanni Rezza, Mariarosaria Boccellino, Annalisa Capuano, Francesco Rossi, Marcello Gelormini, Danilo Lo Fo Wong, Francesco Blasi, Cristiana Bellan, Maurizio Acampa, Matteo Bassetti

Objective: Antimicrobial resistance (AMR) poses a significant and growing threat to public health globally, with Italy facing some of the highest resistance rates in Europe. This manuscript reviewed recent Italian intervention studies aimed at mitigating AMR across bacterial, fungal, and viral domains.

Methods: Strategies including antimicrobial stewardship (AMS), infection prevention and control (IPC), antifungal stewardship (AFS), and diagnostic advancements were evaluated. The evidence highlighted both the promise and limitations of Italy's current approach.

Results: While AMS and IPC programs have reduced antibiotic use, healthcare-associated infections, and costs, regional disparities, inconsistent implementation, and limited longitudinal surveillance remain critical challenges. The fungal resistance landscape is marked by rising threats like Candida auris, requiring urgent expansion of AFS programs. Italy's AMR strategy would benefit from improved IPC infrastructure, realtime data integration, and alignment with One Health principles.

Conclusions: Strengthening national coordination, supportinginnovation, and translating surveillance into action at the local level are crucial for turning policy into measurable progress. This review provides actionable insights to guide a more unified and responsive national AMR framework.

抗菌素耐药性(AMR)对全球公共卫生构成了重大且日益严重的威胁,意大利是欧洲耐药性最高的国家之一。这篇手稿回顾了最近意大利旨在减轻细菌、真菌和病毒领域AMR的干预研究。评估了抗菌素管理(AMS)、感染预防和控制(IPC)、抗真菌管理(AFS)和诊断进展等策略。这些证据突出了意大利目前做法的希望和局限性。虽然AMS和IPC项目减少了抗生素的使用、医疗保健相关的感染和成本,但区域差异、不一致的实施和有限的纵向监测仍然是关键的挑战。真菌耐药性的特点是念珠菌等威胁不断上升,需要紧急扩大AFS计划。意大利的抗微生物药物耐药性战略将受益于改进的IPC基础设施、实时数据整合以及与“同一个健康”原则保持一致。加强国家协调,支持创新,并将监测转化为地方一级的行动,对于将政策转化为可衡量的进展至关重要。该审查提供了可操作的见解,以指导更统一和响应性更强的国家抗菌素耐药性框架。
{"title":"Intervention studies and antimicrobial resistance in Italy: An overview of the latest evidence.","authors":"Antonio Vitiello, Andrea Zovi, Michela Sabbatucci, Elisa Fabbro, Walter Ricciardi, Leonardo Villani, Giovanni Rezza, Mariarosaria Boccellino, Annalisa Capuano, Francesco Rossi, Marcello Gelormini, Danilo Lo Fo Wong, Francesco Blasi, Cristiana Bellan, Maurizio Acampa, Matteo Bassetti","doi":"10.1016/j.jgar.2025.12.017","DOIUrl":"10.1016/j.jgar.2025.12.017","url":null,"abstract":"<p><strong>Objective: </strong>Antimicrobial resistance (AMR) poses a significant and growing threat to public health globally, with Italy facing some of the highest resistance rates in Europe. This manuscript reviewed recent Italian intervention studies aimed at mitigating AMR across bacterial, fungal, and viral domains.</p><p><strong>Methods: </strong>Strategies including antimicrobial stewardship (AMS), infection prevention and control (IPC), antifungal stewardship (AFS), and diagnostic advancements were evaluated. The evidence highlighted both the promise and limitations of Italy's current approach.</p><p><strong>Results: </strong>While AMS and IPC programs have reduced antibiotic use, healthcare-associated infections, and costs, regional disparities, inconsistent implementation, and limited longitudinal surveillance remain critical challenges. The fungal resistance landscape is marked by rising threats like Candida auris, requiring urgent expansion of AFS programs. Italy's AMR strategy would benefit from improved IPC infrastructure, realtime data integration, and alignment with One Health principles.</p><p><strong>Conclusions: </strong>Strengthening national coordination, supportinginnovation, and translating surveillance into action at the local level are crucial for turning policy into measurable progress. This review provides actionable insights to guide a more unified and responsive national AMR framework.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":"288-296"},"PeriodicalIF":3.2,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deconstructing antimicrobial resistance national action plans: A gender-perspective driven mixed-methods analysis. 解构抗菌素耐药性国家行动计划:性别视角驱动的混合方法分析。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-08 DOI: 10.1016/j.jgar.2026.01.001
Magdalena Gatsch, Charlotte Aldridge, Kasim Allel, Hassanat Mojirola Lawal, Esmita Charani, Emma Pitchforth

Introduction: Antimicrobial resistance (AMR) is a major global health threat addressed through National Action Plans (NAPs) aligned with the WHO Global Action Plan. Despite evidence that women are disproportionately affected - receiving 27% more antibiotic prescriptions than men - gender considerations remain largely absent from AMR policies.

Methods: We conducted a mixed-methods analysis of 132 NAPs published before December 2023. A two-stage approach was used: quantitative keyword frequency analysis of 10 gender-related terms (e.g., sex, gender, women), followed by a qualitative thematic analysis of top-tier NAPs, defined as those scoring ≥3 gender-related terms on a 10-point frequency scale derived from the former quantitative analysis. We also examined the gender composition of NAP curators and assessed correlations between gender representation and keyword inclusion.

Results: Only 14 NAPs (11%) mentioned the term 'gender'. The most frequent gender-related term was 'urinary tract infection' (UTI), appearing in 33% of NAPs. High-scoring NAPs were predominantly from low-income countries (mean score 2.4, SD = 2.2), especially in Africa (mean 2.5, SD = 2.3), compared to upper-middle-income countries (mean 1.1, SD = 1.07) and the Pan-American region (mean 1.0, SD = 0.9). Women were underrepresented among NAP curators: 47 NAPs were led entirely by men, while only 14 were led by women. No significant correlation was found between women's participation and gender keyword inclusion (β ≈ 0.11, P = 0.449).

Conclusion: Gender remains insufficiently integrated into AMR NAPs. The findings highlight the need for gender awareness policy development and the adoption of an intersectional framework to address overlapping social determinants that shape AMR vulnerability and response.

抗菌素耐药性是一项主要的全球健康威胁,可通过与世卫组织全球行动计划相一致的国家行动计划加以解决。尽管有证据表明,女性受到的影响不成比例——接受的抗生素处方比男性多27%——但在抗生素耐药性政策中,性别因素仍然基本缺失。方法:我们对2023年12月前发表的132篇nap进行了混合方法分析。采用两阶段方法:定量分析10个性别相关术语(例如,sex, gender, women)的关键词频率,然后对顶级nap进行定性专题分析,定义为在前一阶段定量分析衍生的10分频率量表中得分≥3个性别相关术语。我们还研究了NAP策展人的性别构成,并评估了性别代表性与关键词包含之间的相关性。结果:只有14个nap(11%)提到了“性别”一词。最常见的性别相关术语是“尿路感染”(UTI),出现在33%的nap中。与中高收入国家(平均1.1分,SD=1.07)和泛美地区(平均1.0分,SD=0.9)相比,得分较高的nap主要来自低收入国家(平均2.4分,SD=2.2),尤其是非洲国家(平均2.5分,SD=2.3)。女性在NAP策展人中的比例不足:47个NAP完全由男性领导,而只有14个由女性领导。女性参与与性别关键词纳入无显著相关(β≈0.11,p=0.449)。结论:性别仍未充分纳入抗菌素耐药性nap。研究结果强调,需要提高性别意识,制定政策,并采用交叉框架,以解决影响抗菌素耐药性脆弱性和应对措施的重叠社会决定因素。
{"title":"Deconstructing antimicrobial resistance national action plans: A gender-perspective driven mixed-methods analysis.","authors":"Magdalena Gatsch, Charlotte Aldridge, Kasim Allel, Hassanat Mojirola Lawal, Esmita Charani, Emma Pitchforth","doi":"10.1016/j.jgar.2026.01.001","DOIUrl":"10.1016/j.jgar.2026.01.001","url":null,"abstract":"<p><strong>Introduction: </strong>Antimicrobial resistance (AMR) is a major global health threat addressed through National Action Plans (NAPs) aligned with the WHO Global Action Plan. Despite evidence that women are disproportionately affected - receiving 27% more antibiotic prescriptions than men - gender considerations remain largely absent from AMR policies.</p><p><strong>Methods: </strong>We conducted a mixed-methods analysis of 132 NAPs published before December 2023. A two-stage approach was used: quantitative keyword frequency analysis of 10 gender-related terms (e.g., sex, gender, women), followed by a qualitative thematic analysis of top-tier NAPs, defined as those scoring ≥3 gender-related terms on a 10-point frequency scale derived from the former quantitative analysis. We also examined the gender composition of NAP curators and assessed correlations between gender representation and keyword inclusion.</p><p><strong>Results: </strong>Only 14 NAPs (11%) mentioned the term 'gender'. The most frequent gender-related term was 'urinary tract infection' (UTI), appearing in 33% of NAPs. High-scoring NAPs were predominantly from low-income countries (mean score 2.4, SD = 2.2), especially in Africa (mean 2.5, SD = 2.3), compared to upper-middle-income countries (mean 1.1, SD = 1.07) and the Pan-American region (mean 1.0, SD = 0.9). Women were underrepresented among NAP curators: 47 NAPs were led entirely by men, while only 14 were led by women. No significant correlation was found between women's participation and gender keyword inclusion (β ≈ 0.11, P = 0.449).</p><p><strong>Conclusion: </strong>Gender remains insufficiently integrated into AMR NAPs. The findings highlight the need for gender awareness policy development and the adoption of an intersectional framework to address overlapping social determinants that shape AMR vulnerability and response.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":"273-282"},"PeriodicalIF":3.2,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-risk Pseudomonas aeruginosa clones ST308, ST773 and ST233 associated with carbapenem-resistant and extensively drug-resistant (XDR) isolates from hospital and community setting in Casablanca, Morocco. 摩洛哥卡萨布兰卡医院和社区环境中与碳青霉烯耐药和广泛耐药(XDR)分离株相关的高风险铜绿假单胞菌ST308、ST773和ST233克隆
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-05 DOI: 10.1016/j.jgar.2025.12.012
Ihssane Benzaarate, Fatima El Otmani, Aboubakr Khazaz, Francois Lebreton, Sylvain Brisse, Kaotar Nayme

Backgroud: The spread of high-risk XDR Pseudomonas aeruginosa (Pa) clones is a global threat to public health. In Morocco, data on circulating clones, and genomic features of Pa isolates are lacking.

Objectives, materials and methods: Accordingly, this study performed whole-genome sequencing (WGS) (Illumina NextSeq500) of 18 Pa isolates from hospital (n=10) and the community (n=8) to identify their sequence type (ST) affiliation, antimicrobial resistance determinants, virulence factors, and phylogenetic relationships. Isolates were selected based on alarming resistance profiles from strains collected in Casablanca, Morocco between January and December 2021.

Results: These isolates were assigned as sequence type (ST) 773 (n=11), 308 (n=5) and 233 (n=1), in addition to a novel ST4902 for one hospital isolate. Carbapenem-resistance in hospital isolates was primarily attributed to acquired carbapenemases (NDM-1 in ST773 and ST308 clones). In contrast, resistance in one hospital (CSPa93) and one community isolate (cSPa43) was associated with mutations in outer membrane protein. Fluoroquinolone resistance correlated with the carriage of qnrVC1 and crpP genes, along with mutations in the quinolone resistance-determining regions (QRDR). The isolates also carried diverse aminoglycoside modifying enzymes and 16S rRNAmethyltransferase genes. Genomic analysis also identified multiple virulence genes in these isolates, notably exoU in ST308 and ST773 isolates. Phylogenetic analysis further revealed hospital-adapted strains being genetically related to each other and to community strains.

Conclusion: This first genomic investigation of circulating XDR Pa clones in both hospital and community settings in Morocco using WGS highlights the urgent need for enhanced surveillance and targeted strategies to contain the spread of XDR high-risk clones.

背景:高风险XDR铜绿假单胞菌(Pa)克隆的传播是对全球公共卫生的威胁。在摩洛哥,缺乏关于循环克隆和疟原虫分离株基因组特征的数据。目的、材料和方法:因此,本研究对来自医院(n=10)和社区(n=8)的18株Pa分离株进行了全基因组测序(Illumina NextSeq500),以确定它们的序列类型(ST)隶属关系、抗微生物药物耐药性决定因素、毒力因子和系统发育关系。根据从2021年1月至12月在摩洛哥卡萨布兰卡收集的菌株中惊人的耐药性概况选择分离株。结果:这些分离株被分配为序列型(ST) 773 (n=11), 308 (n=5)和233 (n=1),此外还有一个医院分离株的新序列型ST4902。医院分离株碳青霉烯耐药主要归因于获得性碳青霉烯酶(ST773和ST308克隆中的NDM-1)。相比之下,一家医院(CSPa93)和一家社区分离株(cSPa43)的耐药性与外膜蛋白突变有关。氟喹诺酮类药物耐药与qnrVC1和crpP基因的携带以及喹诺酮类药物耐药决定区(QRDR)的突变相关。这些分离物还携带多种氨基糖苷修饰酶和16S rRNAmethyltransferase基因。基因组分析还在这些分离株中发现了多个毒力基因,特别是ST308和ST773分离株中的exoU。系统发育分析进一步揭示了医院适应菌株彼此之间以及与社区菌株之间存在遗传相关性。结论:利用WGS对摩洛哥医院和社区环境中流行的XDR Pa克隆进行的首次基因组调查突出了迫切需要加强监测和有针对性的战略,以遏制XDR高风险克隆的传播。
{"title":"High-risk Pseudomonas aeruginosa clones ST308, ST773 and ST233 associated with carbapenem-resistant and extensively drug-resistant (XDR) isolates from hospital and community setting in Casablanca, Morocco.","authors":"Ihssane Benzaarate, Fatima El Otmani, Aboubakr Khazaz, Francois Lebreton, Sylvain Brisse, Kaotar Nayme","doi":"10.1016/j.jgar.2025.12.012","DOIUrl":"https://doi.org/10.1016/j.jgar.2025.12.012","url":null,"abstract":"<p><strong>Backgroud: </strong>The spread of high-risk XDR Pseudomonas aeruginosa (Pa) clones is a global threat to public health. In Morocco, data on circulating clones, and genomic features of Pa isolates are lacking.</p><p><strong>Objectives, materials and methods: </strong>Accordingly, this study performed whole-genome sequencing (WGS) (Illumina NextSeq500) of 18 Pa isolates from hospital (n=10) and the community (n=8) to identify their sequence type (ST) affiliation, antimicrobial resistance determinants, virulence factors, and phylogenetic relationships. Isolates were selected based on alarming resistance profiles from strains collected in Casablanca, Morocco between January and December 2021.</p><p><strong>Results: </strong>These isolates were assigned as sequence type (ST) 773 (n=11), 308 (n=5) and 233 (n=1), in addition to a novel ST4902 for one hospital isolate. Carbapenem-resistance in hospital isolates was primarily attributed to acquired carbapenemases (NDM-1 in ST773 and ST308 clones). In contrast, resistance in one hospital (CSPa93) and one community isolate (cSPa43) was associated with mutations in outer membrane protein. Fluoroquinolone resistance correlated with the carriage of qnrVC1 and crpP genes, along with mutations in the quinolone resistance-determining regions (QRDR). The isolates also carried diverse aminoglycoside modifying enzymes and 16S rRNAmethyltransferase genes. Genomic analysis also identified multiple virulence genes in these isolates, notably exoU in ST308 and ST773 isolates. Phylogenetic analysis further revealed hospital-adapted strains being genetically related to each other and to community strains.</p><p><strong>Conclusion: </strong>This first genomic investigation of circulating XDR Pa clones in both hospital and community settings in Morocco using WGS highlights the urgent need for enhanced surveillance and targeted strategies to contain the spread of XDR high-risk clones.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Terrestrial plastisphere as a reservoir of high-risk mcr-1-positive Escherichia coli ST744 in a farmhouse 农家院陆源塑料圈作为mcr-1阳性大肠杆菌ST744的高危宿主
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.11.015
João Pedro Rueda Furlan , Rafael da Silva Rosa , Micaela Santana Ramos , Lucas David Rodrigues dos Santos , Eliana Guedes Stehling
{"title":"Terrestrial plastisphere as a reservoir of high-risk mcr-1-positive Escherichia coli ST744 in a farmhouse","authors":"João Pedro Rueda Furlan ,&nbsp;Rafael da Silva Rosa ,&nbsp;Micaela Santana Ramos ,&nbsp;Lucas David Rodrigues dos Santos ,&nbsp;Eliana Guedes Stehling","doi":"10.1016/j.jgar.2025.11.015","DOIUrl":"10.1016/j.jgar.2025.11.015","url":null,"abstract":"","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 146-147"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145677860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The epidemiological and molecular characteristics and sulbactam-durlobactam susceptibility of carbapenem-resistant Acinetobacter baumannii in a Chinese teaching hospital 某教学医院耐碳青霉烯鲍曼不动杆菌流行病学、分子特征及舒巴坦-杜罗巴坦敏感性分析。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.12.003
Hanlian Huang , Qiaomin Zhang , Shaobo Li , Xiaoyan Dai, Zhongbiao Chen, Guili Zhang, Wen Ma, Hongwei Shen

Objectives

This study aimed to investigate sulbactam-durlobactam (SUL-DUR) susceptibility and molecular features of carbapenem-resistant Acinetobacter baumannii (CRAB) isolates from a Shenzhen teaching hospital.

Methods

A retrospective study on CRAB was conducted from January 2018 to June 2025. Isolates were screened for gyrB and β-lactamase genes (blaOXA-23, −24, −51, and −58). Multi-locus sequence typing (MLST) was used for genotyping, and SUL-DUR susceptibility was tested by disk diffusion. The SUL-DUR-resistant isolate underwent whole-genome sequencing to identify resistance mechanisms.

Results

Of 741 non-duplicate A. baumannii isolates, 147 were CRAB, with its annual percentage rising from 11.4% (2018) to 47.2% (2025). Most isolates came from the ICU (53.7%), and affected patients were predominantly aged ≥60 years (62.6%). Sputum was the primary source (49.7%). Resistance rates exceeded 90% for multiple antibiotics, but only one isolate (0.7%) was resistant to SUL-DUR. This strain harbored nine resistance genes (including blaOXA-23 and blaOXA-66) and had substitutions in penicillin-binding protein 2 (PBP2) and a putative D-Ala-D-Ala carboxypeptidase.
Five sequence types (STs) were identified, including ST2, ST877, ST133, ST195, and a novel sequence type (ST3267), with ST2 being predominant (96.6%). The blaOXA-23 gene was present in 72.8% of isolates, while blaOXA-24 was rare (2.7%). All isolates carried intrinsic blaOXA-51 and gyrB, but blaOXA-58 was absent.

Conclusions

The increasing percentage of carbapenem-resistance among A. baumannii, dominated by ST2 and blaOXA-23-positive strains, highlights an urgent need for stricter infection control. Meanwhile, the notable in vitro susceptibility of CRAB to SUL-DUR offers a promising therapeutic alternative for patients infected with CRAB.
目的:研究深圳某教学医院耐碳青霉烯鲍曼不动杆菌(CRAB)的舒巴坦-杜罗巴坦(su -dur)敏感性及分子特征。方法:于2018年1月至2025年6月对螃蟹进行回顾性研究。筛选分离株gyrB和β-内酰胺酶基因(blaOXA-23、-24、-51和-58)。采用多位点序列分型(Multi-locus sequence typing, MLST)进行基因分型,并采用纸片扩散法检测sol - dur的敏感性。对sulr - durr耐药分离物进行全基因组测序以确定耐药机制。结果:741株非重复鲍曼不动杆菌中,有147株为CRAB,其检出率从2018年的11.4%上升至2025年的47.2%。大多数分离株来自ICU(53.7%),感染患者以年龄≥60岁为主(62.6%)。痰液为主要来源(49.7%)。多种抗生素的耐药率超过90%,但仅有1株(0.7%)对sol - dur耐药。该菌株含有9个耐药基因(包括blaOXA-23和blaOXA-66),并在青霉素结合蛋白2 (PBP2)和推定的D-Ala-D-Ala羧肽酶上有取代。共鉴定出5种序列类型(STs),包括ST2、ST877、ST133、ST195和一种新的序列类型(ST3267),其中ST2占主导地位(96.6%)。blaOXA-23基因在72.8%的分离株中存在,而blaOXA-24基因罕见(2.7%)。所有分离株均含有blaOXA-51和gyrB,但不含blaOXA-58。结论:鲍曼不动杆菌碳青霉烯耐药比例呈上升趋势,以ST2和blaoxa -23阳性菌株为主,迫切需要加强感染控制。同时,螃蟹对su - dur显著的体外敏感性为螃蟹感染患者提供了一个有希望的治疗选择。
{"title":"The epidemiological and molecular characteristics and sulbactam-durlobactam susceptibility of carbapenem-resistant Acinetobacter baumannii in a Chinese teaching hospital","authors":"Hanlian Huang ,&nbsp;Qiaomin Zhang ,&nbsp;Shaobo Li ,&nbsp;Xiaoyan Dai,&nbsp;Zhongbiao Chen,&nbsp;Guili Zhang,&nbsp;Wen Ma,&nbsp;Hongwei Shen","doi":"10.1016/j.jgar.2025.12.003","DOIUrl":"10.1016/j.jgar.2025.12.003","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to investigate sulbactam-durlobactam (SUL-DUR) susceptibility and molecular features of carbapenem-resistant <em>Acinetobacter baumannii</em> (CRAB) isolates from a Shenzhen teaching hospital.</div></div><div><h3>Methods</h3><div>A retrospective study on CRAB was conducted from January 2018 to June 2025. Isolates were screened for <em>gyrB</em> and β-lactamase genes (<em>bla</em>OXA-23, −24, −51, and −58). Multi-locus sequence typing (MLST) was used for genotyping, and SUL-DUR susceptibility was tested by disk diffusion. The SUL-DUR-resistant isolate underwent whole-genome sequencing to identify resistance mechanisms.</div></div><div><h3>Results</h3><div>Of 741 non-duplicate <em>A. baumannii</em> isolates, 147 were CRAB, with its annual percentage rising from 11.4% (2018) to 47.2% (2025). Most isolates came from the ICU (53.7%), and affected patients were predominantly aged ≥60 years (62.6%). Sputum was the primary source (49.7%). Resistance rates exceeded 90% for multiple antibiotics, but only one isolate (0.7%) was resistant to SUL-DUR. This strain harbored nine resistance genes (including <em>bla</em>OXA-23 and <em>bla</em>OXA-66) and had substitutions in penicillin-binding protein 2 (PBP2) and a putative D-Ala-D-Ala carboxypeptidase.</div><div>Five sequence types (STs) were identified, including ST2, ST877, ST133, ST195, and a novel sequence type (ST3267), with ST2 being predominant (96.6%). The <em>bla</em>OXA-23 gene was present in 72.8% of isolates, while <em>bla</em>OXA-24 was rare (2.7%). All isolates carried intrinsic <em>bla</em>OXA-51 and <em>gyrB</em>, but <em>bla</em>OXA-58 was absent.</div></div><div><h3>Conclusions</h3><div>The increasing percentage of carbapenem-resistance among <em>A. baumannii</em>, dominated by ST2 and <em>bla</em>OXA-23-positive strains, highlights an urgent need for stricter infection control. Meanwhile, the notable <em>in vitro</em> susceptibility of CRAB to SUL-DUR offers a promising therapeutic alternative for patients infected with CRAB.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 137-145"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145742994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial resistance in India: Integrating the response into health systems for universal health coverage 印度的抗菌素耐药性:将应对措施纳入全民健康覆盖的卫生系统。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.12.001
Sudha Chandrashekar , Shambhavi Nimisha Prasad , Ramesh Masthi N R , Sheilja Walia , Anushree Trikha , Rajeev Sadanandan

Background

Antimicrobial resistance (AMR) poses a formidable threat to public health in India, requiring a multidimensional response that bridges policy, innovation and intersectoral collaborations. The rapid emergence and spread of multidrug-resistant pathogens driven by the misuse of antimicrobials in human health, animal health, agriculture and environmental settings has rendered many existing therapies obsolete, leaving the population vulnerable to untreatable infections.

Objectives

To examine the multifactorial drivers of AMR in India, review current national and state-level policies and explore the potential role of artificial intelligence (AI) in AMR surveillance, prevention and control.

Methods

This review synthesises evidence from published literature, reports and policy documents. It analyses AMR determinants across human, animal and environmental sectors, evaluates policy frameworks such as India’s National Action Plan and State Action Plans to combat AMR.

Results

Key AMR drivers include antibiotic misuse, inadequate regulation, over-the-counter availability, pharmaceutical and hospital wastewater contamination and gaps in infection prevention. India has come up with national and six state level action plans for AMR containment. The measures include stewardship programs, laboratory network strengthening, spreading awareness and intersectoral coordination. The role of AI in strengthening AMR surveillance and clinical decision-making by integrating complex, high-dimensional data for predictive modelling has been explored.

Conclusion

While India has made significant policy and surveillance advances, enforcement gaps, limited awareness and fragmented data hinder progress. Strengthening governance, expanding One Health surveillance, integrating AI and embedding AMR strategies into universal health coverage are critical to mitigating AMR’s health and economic burden.
背景:抗微生物药物耐药性(AMR)对印度的公共卫生构成巨大威胁,需要在政策、创新和部门间合作之间建立桥梁,采取多方面的应对措施。由于在人类卫生、动物卫生、农业和环境环境中滥用抗微生物药物,导致耐多药病原体的迅速出现和传播,使许多现有疗法过时,使人群容易受到无法治疗的感染。目的:研究印度抗菌素耐药性的多因素驱动因素,审查当前的国家和州一级政策,并探索人工智能(AI)在抗菌素耐药性监测、预防和控制中的潜在作用。方法:本综述综合了已发表的文献、报告和政策文件的证据。报告分析了人类、动物和环境部门的抗微生物药物耐药性决定因素,评估了印度《国家行动计划》和《国家抗微生物药物耐药性行动计划》等政策框架。结果:抗生素耐药性的主要驱动因素包括抗生素滥用、监管不足、非处方药可及性、制药和医院废水污染以及感染预防方面的差距。印度已经提出了国家和六个邦一级的抗微生物药物耐药性控制行动计划。这些措施包括管理计划、加强实验室网络、传播意识和部门间协调。通过整合复杂的高维数据进行预测建模,人工智能在加强抗菌素耐药性监测和临床决策中的作用已经得到了探索。结论:虽然印度在政策和监督方面取得了重大进展,但执法差距、意识有限和数据碎片化阻碍了进展。加强治理、扩大“一种健康”监测、整合人工智能以及将抗菌素耐药性战略纳入全民健康覆盖,对于减轻抗菌素耐药性的健康和经济负担至关重要。
{"title":"Antimicrobial resistance in India: Integrating the response into health systems for universal health coverage","authors":"Sudha Chandrashekar ,&nbsp;Shambhavi Nimisha Prasad ,&nbsp;Ramesh Masthi N R ,&nbsp;Sheilja Walia ,&nbsp;Anushree Trikha ,&nbsp;Rajeev Sadanandan","doi":"10.1016/j.jgar.2025.12.001","DOIUrl":"10.1016/j.jgar.2025.12.001","url":null,"abstract":"<div><h3>Background</h3><div>Antimicrobial resistance (AMR) poses a formidable threat to public health in India, requiring a multidimensional response that bridges policy, innovation and intersectoral collaborations. The rapid emergence and spread of multidrug-resistant pathogens driven by the misuse of antimicrobials in human health, animal health, agriculture and environmental settings has rendered many existing therapies obsolete, leaving the population vulnerable to untreatable infections.</div></div><div><h3>Objectives</h3><div>To examine the multifactorial drivers of AMR in India, review current national and state-level policies and explore the potential role of artificial intelligence (AI) in AMR surveillance, prevention and control.</div></div><div><h3>Methods</h3><div>This review synthesises evidence from published literature, reports and policy documents. It analyses AMR determinants across human, animal and environmental sectors, evaluates policy frameworks such as India’s National Action Plan and State Action Plans to combat AMR.</div></div><div><h3>Results</h3><div>Key AMR drivers include antibiotic misuse, inadequate regulation, over-the-counter availability, pharmaceutical and hospital wastewater contamination and gaps in infection prevention. India has come up with national and six state level action plans for AMR containment. The measures include stewardship programs, laboratory network strengthening, spreading awareness and intersectoral coordination. The role of AI in strengthening AMR surveillance and clinical decision-making by integrating complex, high-dimensional data for predictive modelling has been explored.</div></div><div><h3>Conclusion</h3><div>While India has made significant policy and surveillance advances, enforcement gaps, limited awareness and fragmented data hinder progress. Strengthening governance, expanding One Health surveillance, integrating AI and embedding AMR strategies into universal health coverage are critical to mitigating AMR’s health and economic burden.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 195-202"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145827902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcome comparison between adjunctive clindamycin vs. linezolid for invasive group A streptococcal infection 辅助克林霉素与利奈唑胺治疗侵袭性A组链球菌感染的临床结果比较。
IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2026-01-01 DOI: 10.1016/j.jgar.2025.12.013
Eriko Hashimoto , Sayaka Yoshida , Taito Kitano

Purpose

Although the non-inferiority of adjunctive linezolid (LZD) was indicated for the treatment of invasive group A streptococcal (iGAS) infection, compared with adjunctive clindamycin (CLDM), additional evaluation of comparative effectiveness by subpopulation may further strengthen the evidence. We compared the efficacy of CLDM and LZD combination therapy for iGAS infection.

Methods

In this retrospective cohort study, data were extracted and analysed using TriNetX, a multicentre database. Data were extracted from 1 January 2015 to 30 April 2025, creating two cohorts (adjunctive CLDM and LZD groups). The primary endpoint was mortality within 90 d from diagnosis, which was compared between groups using propensity score matching. Subgroup analyses were conducted according to age, concomitant intravenous immunoglobulin treatment, and study period.

Results

For analysis, 5841 cases were identified in the CLDM combination group and 1426 in the LZD group. The primary endpoint was observed in 170 (12.0%) cases in the CLDM group and 195 (13.8%) in the LZD group. Odds ratio was 0.854 (95% confidence interval 0.685–1.065, P = 0.161), with odds ratio <1 indicating a CLDM-favourable result.

Conclusions

Clinical efficacy of adjunctive CLDM and LZD was compared in patients with iGAS infection. No significant difference in mortality was observed in the overall population. LZD may be a potential alternative in cases where CLDM use is limited by resistance, intolerance, or contraindications.
目的:虽然与辅助克林霉素(CLDM)相比,辅助利奈唑胺(LZD)治疗侵袭性A组链球菌(iGAS)感染具有非劣效性,但对亚群比较效果的额外评价可能会进一步加强证据。我们比较了CLDM和LZD联合治疗iGAS感染的疗效。方法:在这项回顾性队列研究中,使用TriNetX多中心数据库提取数据并进行分析。数据从2015年1月1日至2025年4月30日提取,创建两个队列(辅助CLDM组和LZD组)。主要终点是诊断后90天内的死亡率,使用倾向评分匹配(PSM)进行组间比较。根据年龄、同时静脉注射免疫球蛋白(IVIG)治疗和研究时间进行亚组分析。结果:在分析中,CLDM联合组有5841例,LZD组有1426例。CLDM组170例(12.0%)和LZD组195例(13.8%)观察到主要终点。优势比(OR)为0.854(95%可信区间0.685-1.065,p=0.161), OR。结论:比较iGAS感染患者辅助CLDM与LZD的临床疗效。在总体人群中没有观察到死亡率的显著差异。如果CLDM的使用受到耐药性、不耐受或禁忌症的限制,LZD可能是一种潜在的替代方案。
{"title":"Clinical outcome comparison between adjunctive clindamycin vs. linezolid for invasive group A streptococcal infection","authors":"Eriko Hashimoto ,&nbsp;Sayaka Yoshida ,&nbsp;Taito Kitano","doi":"10.1016/j.jgar.2025.12.013","DOIUrl":"10.1016/j.jgar.2025.12.013","url":null,"abstract":"<div><h3>Purpose</h3><div>Although the non-inferiority of adjunctive linezolid (LZD) was indicated for the treatment of invasive group A streptococcal (iGAS) infection, compared with adjunctive clindamycin (CLDM), additional evaluation of comparative effectiveness by subpopulation may further strengthen the evidence. We compared the efficacy of CLDM and LZD combination therapy for iGAS infection.</div></div><div><h3>Methods</h3><div>In this retrospective cohort study, data were extracted and analysed using TriNetX, a multicentre database. Data were extracted from 1 January 2015 to 30 April 2025, creating two cohorts (adjunctive CLDM and LZD groups). The primary endpoint was mortality within 90 d from diagnosis, which was compared between groups using propensity score matching. Subgroup analyses were conducted according to age, concomitant intravenous immunoglobulin treatment, and study period.</div></div><div><h3>Results</h3><div>For analysis, 5841 cases were identified in the CLDM combination group and 1426 in the LZD group. The primary endpoint was observed in 170 (12.0%) cases in the CLDM group and 195 (13.8%) in the LZD group. Odds ratio was 0.854 (95% confidence interval 0.685–1.065, <em>P</em> = 0.161), with odds ratio &lt;1 indicating a CLDM-favourable result.</div></div><div><h3>Conclusions</h3><div>Clinical efficacy of adjunctive CLDM and LZD was compared in patients with iGAS infection. No significant difference in mortality was observed in the overall population. LZD may be a potential alternative in cases where CLDM use is limited by resistance, intolerance, or contraindications.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"46 ","pages":"Pages 241-245"},"PeriodicalIF":3.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145827940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of global antimicrobial resistance
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1